Taenia crassiceps Antigens Control Experimental Type 1 Diabetes by Inducing Alternatively Activated Macrophages

Figure 8

Clodronate treatment abrogates protection against T1D in mice receiving TcS. The clodronate-liposome injections followed the same experimental design as the T. crassiceps infection process. Mice were injected with TcS 1 week before T1D induction and continue receiving the treatment for 4 weeks post T1D induction. Blood glucose was measured for 4 consecutive weeks. Differences between STZ/TcS Cl and STZ/TcS PBS. Data are representative by 2 independent experiments, each group with 4 mice. Mean ± SEM. by the Mann–Whitney U test.